Navigation Links
Legionella bacteria found in compost products
Date:10/1/2013

A study conducted at the University of Strathclyde investigating the presence of Legionella in compost, has found that the bacteria exist in a significant number of commercial products.

The research, the first substantial analysis of Legionella in UK composts, suggests that the bacteria are a common part of the microflora found within the composts tested.

It is widely recognised that Legionella bacteria are commonly present in the environment and the researchers have found that compost could be a potential source of infection.

Dr Tara K. Beattie, of the University of Strathclyde's Department of Civil and Environmental Engineering, said: "Disease causing micro-organisms are widespread in the environment, and therefore it is not too surprising that species of Legionella that can cause human disease are present in compost.

"Any environment where you have pathogenic bacteria could be a source of infection, and we already know that compost has been linked to human Legionella infection in countries such as Australia and New Zealand.

"Within the UK and across Europe composts have traditionally been composed of peat, whereas sawdust and bark are more often used to produce compost in Australia and New Zealand where Legionellosis associated with compost is more common.

"It may be that the change in composition of composts in the UK, moving away from peat based products, could be resulting in species such as Legionella longbeachae being present in compost and therefore more cases of infection could occur."

The study was conducted by Dr Beattie, fellow academic Dr Charles Knapp, Strathclyde PhD student Sandra Currie and Dr Diane Lindsay of the Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory.

Twenty two different brands of compost, commercially available in the UK, were examined for the presence of Legionella b
'/>"/>

Contact: John Beaton
john.beaton@strath.ac.uk
44-141-548-2924
University of Strathclyde
Source:Eurekalert

Page: 1 2

Related biology news :

1. Infection biology: How Legionella subverts to survive
2. Mechanism discovered which aids Legionella to camouflage itself in the organism
3. How bacteria integrate autotransporters into their outer membrane
4. Bacteria responsible for gum disease facilitates rheumatoid arthritis
5. Stomach bacteria switch off human immune defences to cause disease
6. Rich or poor in gut bacteria brings new vision for obesity treatment
7. Bacterial toxins cause deadly heart disease
8. UC Davis researchers discover molecular target for the bacterial infection brucellosis
9. High-angle helix helps bacteria swim
10. Newly discovered bacterial partnership changes ocean chemistry
11. Bacterial blockade
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... SHENZHEN, China , 31 de julho de 2015 ... Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de ... China . A conferência está ... inauguração em 2006, a ICG se tornou uma das ... e um dos encontros científicos mais dinâmicos, entusiastas e ...
(Date:7/31/2015)... La 10 th International Conference on Genomics ... 22 al 25 de octubre de 2015 en ... conferencia celebra su décimo aniversario. Desde su inauguración en el ... reuniones anuales más influyentes del mundo en el campo ,ómico, ... y mejores a nivel científico. ICG-10 se ...
(Date:7/31/2015)... OXFORD, Conn. , Jul. 31, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces that it has filed provisional patent 62/198989 for ... This invention highlights a method to advance crypto-currencies ... technology by introducing a common, uniform way to manage ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... Current research suggests that T helper-type 1 (Th1) ... the development of experimental immune encephalomyelitis (EAE), a mouse ... The related report by Wildbaum et al, "Antigen-specific ... CD4 + T cells restrain the development ...
... many oxygen-free environments may be "carbon-breathing" as well. ... "mineral-breathing" because they use iron oxides and other minerals ... a study published online May 23 in the journal ... accelerated by solid organic compounds in the soil. ...
... Md. , May 7 Scientists from ... 5th to advocate for increased funding for federal science agencies ... Experimental Biology,s (FASEB) annual Capitol Hill Day.  Led by FASEB President, ... congressional offices and attended breakfast events with two members of the ...
Cached Biology News:When helper cells aren't helpful 2Organic solids in soil may speed up bacterial breathing 2FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding 2
(Date:8/27/2015)... , ... August 27, 2015 , ... ... for venture capital funds, investment firms and animal health companies to hear from ... raised $160 million. Several have also received licensing agreements or distribution contracts. ...
(Date:8/27/2015)... Aug. 27, 2015  Neogen Corporation (NASDAQ: NEOG ... of United Kingdom -based Lab M ... media and diagnostic systems. Lab M ... leading provider of microbial testing and diagnostic products for ... The company currently sells into more than 70 countries ...
(Date:8/27/2015)... Fla. , Aug. 27, 2015 The ... that a patient,s eyes—and life—were saved by doctors at ... , working with NNFF, NovaBay Pharmaceuticals and Dr. ... Care Center at Seton Medical Center in ... successful treatment used a breakthrough approach, pioneered by Dr. ...
(Date:8/27/2015)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its ... Biorem,s complete second quarter financial statements and MD&A have been filed ... earnings per shareThree-months ended , Six -months endedJune 30 , June ... , 2014 Revenue , 4,709 , 2,459 ... 1,656 , 56 , 3,188 ...
Breaking Biology Technology:VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Neogen acquires U.K.-based Lab M Holdings 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3
... ... , ... Ind. (Vocus) June 17, 2009 –- Pioneer Hi-Bred , a DuPont business, ... to bring additional corn and soybean products to growers in the marketplace. Under these ...
... 17 Campbell Alliance, the leading management consulting firm ... that it has appointed industry veterans Jon W. McGarity ... gentlemen will work directly with John Campbell, CEO of ... advise the firm,s emerging and midsize client companies. ...
... QC, June 17 /PRNewswire-FirstCall/ - BioSyntech, Inc. (TSX: ... regenerative medicine, today announced statistically significant results from ... month follow-up in the BST-CarGel(R) randomized clinical trial. ... quality due to BST-CarGel treatment was found during ...
Cached Biology Technology:Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements 2Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements 3Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 2Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 3Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 4BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 2BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 3BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 4BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 5